CN114468280A - Enzyme for preventing obesity and regulating intestinal flora and preparation method and application thereof - Google Patents
Enzyme for preventing obesity and regulating intestinal flora and preparation method and application thereof Download PDFInfo
- Publication number
- CN114468280A CN114468280A CN202210213988.4A CN202210213988A CN114468280A CN 114468280 A CN114468280 A CN 114468280A CN 202210213988 A CN202210213988 A CN 202210213988A CN 114468280 A CN114468280 A CN 114468280A
- Authority
- CN
- China
- Prior art keywords
- parts
- aloe
- ferment
- intestinal flora
- fruit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 54
- 208000008589 Obesity Diseases 0.000 title claims abstract description 32
- 235000020824 obesity Nutrition 0.000 title claims abstract description 31
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 108090000790 Enzymes Proteins 0.000 title description 18
- 102000004190 Enzymes Human genes 0.000 title description 18
- 238000000855 fermentation Methods 0.000 claims abstract description 70
- 230000004151 fermentation Effects 0.000 claims abstract description 70
- 239000011550 stock solution Substances 0.000 claims abstract description 51
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 45
- 241001116389 Aloe Species 0.000 claims abstract description 33
- 235000012055 fruits and vegetables Nutrition 0.000 claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 30
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 10
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 10
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 10
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 10
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 10
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 10
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 10
- 235000000346 sugar Nutrition 0.000 claims description 31
- 235000013305 food Nutrition 0.000 claims description 15
- 244000144927 Aloe barbadensis Species 0.000 claims description 12
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 12
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 6
- 244000298697 Actinidia deliciosa Species 0.000 claims description 5
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 5
- 235000009467 Carica papaya Nutrition 0.000 claims description 5
- 240000006432 Carica papaya Species 0.000 claims description 5
- 235000005979 Citrus limon Nutrition 0.000 claims description 5
- 244000131522 Citrus pyriformis Species 0.000 claims description 5
- 240000000249 Morus alba Species 0.000 claims description 5
- 235000008708 Morus alba Nutrition 0.000 claims description 5
- 240000002624 Mespilus germanica Species 0.000 claims description 4
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 4
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 4
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 206010033546 Pallor Diseases 0.000 claims description 3
- 241000220317 Rosa Species 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 240000004507 Abelmoschus esculentus Species 0.000 claims description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 2
- 240000007474 Aloe arborescens Species 0.000 claims description 2
- 235000004509 Aloe arborescens Nutrition 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 241000207199 Citrus Species 0.000 claims description 2
- 240000000560 Citrus x paradisi Species 0.000 claims description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 2
- 244000157072 Hylocereus undatus Species 0.000 claims description 2
- 235000018481 Hylocereus undatus Nutrition 0.000 claims description 2
- 241000220225 Malus Species 0.000 claims description 2
- 235000011430 Malus pumila Nutrition 0.000 claims description 2
- 235000015103 Malus silvestris Nutrition 0.000 claims description 2
- 244000131360 Morinda citrifolia Species 0.000 claims description 2
- 241000235342 Saccharomycetes Species 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 235000009569 green tea Nutrition 0.000 claims description 2
- 235000017524 noni Nutrition 0.000 claims description 2
- 210000000028 corpus adiposum pararenale Anatomy 0.000 abstract description 16
- 201000010063 epididymitis Diseases 0.000 abstract description 14
- 241000894006 Bacteria Species 0.000 abstract description 13
- 230000009286 beneficial effect Effects 0.000 abstract description 9
- 230000035755 proliferation Effects 0.000 abstract description 5
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 230000012010 growth Effects 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 45
- 241000699670 Mus sp. Species 0.000 description 44
- 230000000694 effects Effects 0.000 description 22
- 229940088598 enzyme Drugs 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- 230000037396 body weight Effects 0.000 description 9
- 230000009467 reduction Effects 0.000 description 8
- 238000013329 compounding Methods 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 150000008163 sugars Chemical class 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 235000012631 food intake Nutrition 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 3
- 235000006264 Asimina triloba Nutrition 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 3
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 210000000918 epididymis Anatomy 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 235000021552 granulated sugar Nutrition 0.000 description 3
- 235000009200 high fat diet Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000013116 obese mouse model Methods 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 244000181025 Rosa gallica Species 0.000 description 2
- 235000000533 Rosa gallica Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 150000004056 anthraquinones Chemical group 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000008991 intestinal motility Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000021076 total caloric intake Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 244000101643 Aloe ferox Species 0.000 description 1
- 235000015858 Aloe ferox Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 208000010359 Newcastle Disease Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000021310 complex sugar Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A ferment for preventing obesity and regulating intestinal flora and a preparation method and application thereof are disclosed, wherein the ferment is prepared by fermenting the following raw materials: 20-40 parts of aloe fermentation stock solution, 40-60 parts of comprehensive fruit and vegetable fermentation stock solution, 1-15 parts of fructo-oligosaccharide, 1-15 parts of galacto-oligosaccharide and 1-10 parts of trehalose. The ferment can remarkably reduce the weight growth rate, the weight of epididymal fat and perirenal fat, can increase the abundance of intestinal flora, and is beneficial to the proliferation of beneficial bacteria and the inhibition of harmful bacteria.
Description
Technical Field
The invention belongs to the field of health care products. In particular to a ferment for preventing obesity and regulating intestinal flora and a preparation method and application thereof.
Background
The definition of the edible plant enzyme in QB/T5323-2018 plant enzyme, applied by West 1/7 of the Ministry of industry and communications in 2019, is as follows: the plant which can be used for food processing is taken as a main raw material, and an auxiliary material is added or not added, and the product which contains a specific bioactive component and can be eaten by human beings is prepared by microbial fermentation. Almost all cellular processes require enzymes, which are essential for maintaining the normal functions of the body, digesting food, repairing tissues, etc. The main functions of the ferment are: regulating internal environment, and purifying toxin in vivo; the intestinal flora is kept balanced; improving the intestinal peristalsis; strengthening cell function, promoting metabolism, and enhancing immunity.
The human body mainly synthesizes enzymes through food intake and self-synthesis. With the increasing age, the secretion of enzymes in the body is less and less, and meanwhile, the modern people are overnourished and residual toxins in the body cause endocrine dyscrasia and metabolic disorders, so that more enzymes need to be taken from food to maintain the metabolism of the body. However, as food materials are increasingly contaminated, and more elaborate processing methods are used, enzymes in the food are destroyed. Therefore, additional supplementation with ferments is essential for maintaining physical health.
In view of this, the invention is particularly proposed.
Disclosure of Invention
The first object of the present invention is to provide a ferment for preventing obesity and regulating intestinal flora, which can significantly reduce the weight gain rate, the weight of epididymal fat and perirenal fat, increase the abundance of intestinal flora, and contribute to the proliferation of beneficial bacteria and the inhibition of harmful bacteria.
The second objective of the present invention is to provide a method for preparing the above enzyme for preventing obesity and regulating intestinal flora.
The third objective of the present invention is to provide an application of the above enzyme for preventing obesity and regulating intestinal flora in the preparation of a medicament or food for preventing obesity and regulating intestinal flora.
In order to achieve the purpose, the invention adopts the following technical scheme:
a ferment for preventing obesity and regulating intestinal flora is prepared by fermenting the following raw materials: 20-40 parts of aloe fermentation stock solution, 40-60 parts of comprehensive fruit and vegetable fermentation stock solution, 1-15 parts of fructo-oligosaccharide, 1-15 parts of galacto-oligosaccharide and 1-10 parts of trehalose.
The ferment for preventing obesity and regulating intestinal flora as described above is preferably prepared by fermenting the following raw materials: 15-25 parts of aloe fermentation stock solution, 45-55 parts of comprehensive fruit and vegetable fermentation stock solution, 3-12 parts of fructo-oligosaccharide, 3-12 parts of galacto-oligosaccharide and 2-8 parts of trehalose.
The ferment for preventing obesity and regulating intestinal flora as described above, preferably, the aloe is at least one of aloe vera, aloe arborescens and aloe vera.
The ferment for preventing obesity and regulating intestinal flora as described above is preferably prepared from aloe vera gel which is prepared from the leaves of aloe vera by leaching off quinone, cleaning, peeling, blanching and sterilizing.
The ferment for preventing obesity and regulating intestinal flora as described above preferably comprises the following raw materials: lemon, green plum, papaya, kiwi fruit, mulberry, medlar, red date and/or rose.
The ferment for preventing obesity and regulating intestinal flora as described above, preferably, the fruit and vegetable raw materials of the integrated fruit and vegetable fermentation stock solution further include: pineapple, plum, grape, dragon fruit, apple, hawthorn, green tea, okra, corn, mushroom, prune, noni, dark plum, citrus, grapefruit, and/or blueberry.
The preparation method of the ferment for preventing obesity and regulating intestinal flora as described above preferably comprises the following steps:
fermentation in the first stage: fermenting the aloe and the fruit and vegetable raw materials at normal temperature for 3 months to 2 years respectively;
and (3) second-stage fermentation: mixing the aloe and fruit and vegetable fermentation stock solution obtained in the first stage fermentation with the rare sugar according to the weight ratio, and fermenting by adopting lactobacillus plantarum and/or saccharomycetes at the fermentation temperature of 25-36 ℃ for 7-30 days.
The use of the ferment for preventing obesity and regulating intestinal flora as described above in the preparation of a medicament or food for preventing obesity and regulating intestinal flora function.
The weight parts of the aloe fermentation raw liquid, typically but not limited to, for example, may be 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts, 30 parts, 31 parts, 32 parts, 33 parts, 34 parts, 35 parts, 36 parts, 37 parts, 38 parts, 39 parts or 40 parts, and the like.
The total weight parts of the fruit and vegetable fermentation stock solution can be, for example, 40 parts, 41 parts, 42 parts, 43 parts, 44 parts, 45 parts, 46 parts, 47 parts, 48 parts, 49 parts, 50 parts, 51 parts, 52 parts, 53 parts, 54 parts, 55 parts, 56 parts, 57 parts, 58 parts, 59 parts or 60 parts, and the like.
The weight fraction of fructooligosaccharide, which is typical but not limiting, may be, for example, 1 part, 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, or 15 parts, and the like.
The weight fraction of galactooligosaccharide, which is typical but not limiting, may be, for example, 1 part, 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, or 15 parts, and the like.
The trehalose may be, for example, typically but not limited to, 1 part, 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, or 15 parts by weight or the like.
The invention provides a ferment for preventing obesity and adjusting intestinal flora, which takes aloe fermentation stock solution and comprehensive fruit and vegetable fermentation stock solution as main raw materials, adds three kinds of rare sugars of fructo-oligosaccharide, galacto-oligosaccharide and trehalose, organically combines various raw materials, synergizes, jointly adjusts intestinal microecology and corrects sub-health state.
Wherein, the aloe fermentation stock solution is obtained by taking edible parts of edible aloe as raw materials and performing natural fermentation and (or) single (multiple) strain multi-stage fermentation. The Aloe is leaf or juice or concentrated dried product of Aloe Barbadensis Miller, Aloe ferox Miller or other related plants of the same genus of Liliaceae. Aloe vera is considered as one of the best quality aloe, and Aloe vera gel is prepared from leaves of Aloe vera as raw material by leaching off quinone, cleaning, peeling, blanching, sterilizing, etc., and approved as a new resource food by No. 12 bulletin of Ministry of health 2008. According to the record of Chinese pharmacopoeia, aloe gel enters liver, stomach and large intestine channels, is bitter in taste and cold in nature, has the functions of clearing liver heat and relaxing the bowels, and is mainly used for treating constipation and the like.
Although the chemical components of aloe are complex, they are mainly classified into two categories in terms of specificity and efficacy: one is anthraquinone (aloin for short) such as aloin. It is the first recognized and utilized component in aloe, and is one of the main organic active components of aloe gel, and can decompose and activate intestinal bacteria, increase lipase activity, promote intestinal muscle contraction, promote intestinal peristalsis, relax bowels and promote urination, and has obvious effect of treating constipation. The other is polysaccharide, and researches show that the polysaccharide can promote the biosynthesis of protein and nucleic acid, regulate the growth of cells and improve the immunity of a human body.
The comprehensive fruit and vegetable fermentation stock solution is mainly prepared by two or more fermentation processes, is rich in various bioactive substances, and comprises the following components: vitamins, organic acids, polyphenol, polysaccharide, dietary fiber and other small molecular active ingredients and SOD enzyme, and has the functions of activating enzyme and enzyme activity and promoting metabolism.
In the application, lemon, green plum, pawpaw, kiwi fruit, mulberry, medlar, red date and/or double-petal red rose are preferably selected as raw materials, and are fermented into the comprehensive fruit and vegetable fermentation stock solution, wherein,
the lemon contains rich citric acid, is known as a citric acid warehouse, and can promote the production of body fluid, relieve summer heat, stimulate the appetite and activate the spleen; it is also rich in vitamin C, and can maintain the formation of various tissues and intercellular substance of human body and maintain their normal physiological functions. The matrix, the adhesive and the colloid in the human body need vitamin C for protection.
The green plum not only contains rich organic acid, but also can promote the discharge of toxin in vivo, and has the effects of expelling toxin and relaxing bowels.
The pawpaw contains papain, can compensate secretion of pancreas and intestinal tract, supplement insufficiency of gastric juice, and is helpful for decomposing protein and starch.
The kiwi fruit contains abundant vitamin C and a large amount of minerals, and is helpful for maintaining the electrolyte balance of the body.
Pharmacological research shows that: the mulberry entering the stomach can supplement the lack of gastric juice, promote the digestion of gastric juice, enter the intestine and promote the secretion of intestinal juice and the gastrointestinal peristalsis, thereby having the effects of tonifying and strengthening.
The fructus Lycii not only contains fructus Lycii polysaccharide, but also contains betaine, and has effects of supplying methyl in vivo, accelerating lipid metabolism, and resisting fatty liver.
The red date has very high vitamin content, has the reputation of 'natural vitamin pills', and has the effects of nourishing yin and tonifying yang.
The rose with double petals contains 18 amino acids and microelements required by human body, and has the effects of coordinating intestines and stomach and promoting metabolism.
After the 8 raw materials are fermented, macromolecular nutrient components are further decomposed into micromolecular nutrient substances which are easier to absorb by a human body, and the intestinal tract safety is not burdened.
The rare sugar refers to monosaccharide and derivatives with low content in nature, and is very rare compared with glucose and fructose existing in nature in a large amount, and about 50 types exist. The rare sugar can reduce the formation of toxic substances (such as endotoxin, ammonia and the like), has a protective effect on intestinal mucosa cells and liver, can regulate intestinal flora, allows certain microorganisms to be planted in the intestinal tract, provides a proper inhabitation environment for the microorganisms, promotes the improvement and influence of the intestinal mucosa immune function, and participates in various metabolic functions of a human body. According to the specificity of various rare sugars on the action of intestinal flora, the invention screens three rare sugars capable of promoting the proliferation of one or more specific beneficial bacteria for compounding (the action condition of the main beneficial bacteria on the intestinal tract is shown in table 1), and the three rare sugars have complementary advantages and are strong in connection, so that the aims of regulating the intestinal flora, increasing the abundance and diversity of the beneficial bacteria, improving the intestinal motility, promoting defecation, reducing the abundance of harmful bacteria, reducing the generation of endotoxin and metabolic waste and caring the health of the intestinal tract are fulfilled.
TABLE 1 Effect of three rare sugars on major beneficial bacteria in the gut
Note: "+" indicates promotion of proliferation; "-" indicates inhibition of proliferation.
The beneficial effects of the invention are as follows:
(1) the aloe fermentation stock solution and the comprehensive fruit and vegetable fermentation stock solution are prepared by fermenting natural fruits and vegetables by a two-stage process, and the aloe fermentation stock solution contains anthraquinone substances such as aloin and polysaccharide, can decompose and activate intestinal bacteria, increase the activity of lipase, promote intestinal muscle contraction and accelerate intestinal peristalsis; the comprehensive fruit and vegetable fermentation liquor contains various micromolecular active ingredients such as vitamins, organic acids, polyphenol, crude polysaccharide, dietary fiber and the like and SOD enzyme, and has the functions of exciting the enzyme and enzyme activity, promoting metabolism and improving human immunity.
(2) The addition of the selected three rare sugars can regulate intestinal flora, increase the abundance and diversity of beneficial bacteria, improve intestinal motility, promote defecation, reduce the abundance of harmful bacteria and reduce the generation of endotoxin and metabolic waste.
(3) The combination of the fermentation stock solution and the rare sugar achieves the synergistic effect, regulates the intestinal microecology and promotes the metabolism of the Newcastle disease together, so that the ferment can control the weight increase, reduce the inflammatory reaction and obviously reduce the perirenal fat and the content of serum cholesterol. Animal experiments prove that the composition has the obvious effects of reducing the weight growth rate, the weight of epididymal fat and perirenal fat, reducing the inflammation level and regulating intestinal flora.
(4) The invention adopts a two-stage fermentation process, the aloe ferment stock solution and the comprehensive fruit and vegetable fermentation stock solution are taken as base materials in the second stage of fermentation, and three kinds of rare sugar complex sugar are particularly added, so that the problems of high sugar degree and high sugar raising index of the final product caused by adding brown granulated sugar in the prior art are solved, and meanwhile, the secondary fermentation is also significant for promoting the ripening of flavor and improving the taste.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to the following detailed description, but those skilled in the art will understand that the following described examples are some, not all, of the examples of the present invention, and are only used for illustrating the present invention, and should not be construed as limiting the scope of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
Example 1
Aloe fermentation stock solution: processing Aloe barbadensis Miller by: high-efficiency cleaning, slicing, adding brown granulated sugar until the sugar degree is 60, fermenting at normal temperature for 6 months, and filtering to obtain the product.
Synthesizing fruit and vegetable fermentation stock solution: respectively processing lemon, green plum, pawpaw, kiwi fruit, mulberry, red date, double red rose and medlar by: efficient cleaning-slicing-adding brown granulated sugar until the sugar degree is 60, fermenting at normal temperature for 6 months until the sugar degree is below 5, filtering to obtain 8 kinds of fruit and vegetable fermentation stock solutions, and compounding according to the same parts to obtain the fruit and vegetable fermentation stock solutions.
And (3) secondary fermentation: uniformly mixing the aloe fermentation stock solution and (or) the comprehensive fruit and vegetable fermentation stock solution and (or) fructo-oligosaccharide and (or) galacto-oligosaccharide and (or) trehalose according to the proportion listed in the table 2, then implanting lactobacillus plantarum, and fermenting at 29 +/-2 ℃ for 15 days until the pH is less than or equal to 3.6 to obtain a ferment sample 1-10.
TABLE 2 weight parts of each sample raw material
Sample (I) | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
Aloe fermentation stock solution | 20 | - | 20 | 40 | 20 | - | 70 | 20 | 20 | 20 |
Comprehensive fruit and vegetable fermentation stock solution | 50 | - | 40 | 60 | 50 | 70 | - | 50 | 50 | 50 |
Fructo-oligosaccharide | - | 8 | 5 | 15 | 8 | 8 | 8 | - | 13.33 | 10 |
Galacto-oligosaccharides | - | 8 | 7 | 15 | 8 | 8 | 8 | 13.33 | - | 10 |
Trehalose | - | 4 | 4 | 10 | 4 | 4 | 4 | 6.67 | 6.67 | - |
Note: -means not added.
Experimental example experiment of effects of enzymes for preventing obesity and regulating intestinal flora on obesity-suppressing and intestinal flora-improving effects in mice
1. Experimental methods
1.1 Purchase and Adaptation of mice
175C 57BL/6J SPF male mice were purchased from Beijing Wintolite laboratory animal technology Limited at 5 weeks of age and were acclimatized in the central barrier environment of laboratory animals at the university of south Jiangnan for 1 week using maintenance feed. One week later, the mice were numbered and randomly divided into 2 groups according to body weight, 10 mice were given maintenance diet as a blank control group (ND group), and the remaining 165 mice were given high fat diet as a model group.
1.2 Molding screening
High-fat diet was given to the mice of the model group, the food intake, food scatter, food remaining amount, water intake were recorded weekly, the body weight was weighed 1 time, and the food intake, total calorie intake and food utilization rate were calculated therefrom. After 2 weeks of feeding, the mice in the model group were ranked according to weight gain, and mice resistant to obesity were eliminated.
1.3 administration of test samples
And randomly dividing the screened 110 obesity sensitive mice into 11 groups according to the body weight, wherein the 11 groups are respectively a model control group and a sample 1-sample 10 group.
Mice were raised in a single cage on day 0, and their feces were collected and placed in sterilized EP tubes, rapidly frozen in liquid nitrogen, and stored in a-80 deg.C freezer for further use. The model control group, the positive control group and 10 sample groups prepared in example 1 were fed with high-fat diet and the empty control group with maintenance diet, respectively. Mice in groups S1, S2, S3, S4, S5, S6, S7, S8, S9 and S10 were gavaged with 10 samples of the complex prepared in the examples (7.8. mu.L/g), and the model control group and the blank control group were gavaged with the same amount of physiological saline. At the same time, the mice were subjected to gastric lavage for 6 weeks continuously, the food intake, food scattering, food remaining, and water intake were recorded every week, and the body weight was weighed 1 time, from which the food intake, total calorie intake, and food utilization rate were calculated. After week 6, mice in the blank control group, model control group, and sample 1 to sample 10 groups were subjected to CO2Euthanasia treatment and dissection were performed, perirenal fat and epididymal adipose tissue were weighed, and colon contents were taken and placed in a sterilized EP tube, rapidly frozen in liquid nitrogen, and stored in a-80 flash freezer for further use.
1.416S rRNA sequencing
16S rRNA sequencing is carried out on the obtained fecal sample, after a sequencing result is received, effective sequences are screened through QIIME, FLASH and USEARCH software, OTU division is carried out through a UCLUST comparison tool by taking 97% similarity as a threshold value, rare OTU is removed, and the OTU used for analysis is obtained after the sequence is subjected to level extraction treatment. And the representative sequence with the highest richness is used for classification, identification and analysis, an OUT abundance matrix is generated at the same time, a Green genes database is used for comparison during the taxonomic identification of the flora, and the common OUT quantity among different treatment groups is calculated through R software.
Drawing an abundance grade curve according to the OTU abundance distribution of each sample, and calculating an alpha diversity index: simpson, Shannon, Chao 1 and ACE index.
2. Results and analysis of the experiments
2.1 mouse weight Condition
The weight change of the mice is shown in table 3, after the mice are fed with the high-fat feed and the experimental samples for 6 weeks, the weight of the mice in each experimental group is obviously different from that in the model group, the average weight of the mice in the normal group is 24.391g, and the weight of the obese mice reaches 35.936g, which indicates that the molding is successful. The body weight of the sample 2 group was significantly reduced compared to the model group, and the body weight of each of the remaining groups was extremely significantly reduced. The raw materials of sample 2 group did not contain two fermentation stocks, indicating that the two fermentation stocks play a major role in reducing the body weight of obese mice. Meanwhile, compared with the model group, the body weight reduction degree of the sample 1 group containing only two fermentation stock solutions in the raw materials is lower than that of the sample 3-10 groups, which shows that the compounding of the fermentation stock solutions and the rare sugar has the synergistic effect. Compared with the model group, the body weight average of the mice of the sample 3-5 groups is remarkably reduced (p is less than 0.0001), and the reduction degree is better than that of the mice of the sample 6-10 groups. The raw materials of the samples 3-5 consist of two fermentation stock solutions and three kinds of rare sugar, and the experimental result shows that the scheme of compounding the two fermentation stock solutions and the three kinds of rare sugar has the most obvious effect. Wherein, the weight of the mice in the group of sample 5 is reduced the most, and the weight is close to that of the normal mice, which shows that the ferment of sample 5 has the best effect of reducing the weight of the mice.
TABLE 3 weight condition of each group of mice after 6 weeks of administration
Note: # indicates significance compared to the blank control group and # indicates significance compared to the model control group.
2.2 weight changes in mouse tissues
The change of the tissue weight of the mouse is shown in table 4, and the liver, perirenal fat and epididymal fat of the model group are obviously increased compared with those of the blank control group, which indicates that the model building is successful. Compared with the model group, the liver weight of the mice in the sample 4 group is obviously reduced, and the liver weight of the mice in the sample 5 group is extremely obviously reduced. Compared with a model group, the liver weights of mice in the groups of the sample 1, the sample 2 and the sample 6-10 are reduced, but no obvious difference exists, and the results of the control sample 3-5 show that five raw materials, namely fructo-oligosaccharide, galacto-oligosaccharide, trehalose, aloe fermentation stock solution and comprehensive fruit and vegetable fermentation stock solution, have influence on the liver weight of the mice and play a necessary role in the product; meanwhile, the effect of the combination of the two fermentation stock solutions and the three rare sugars on the reduction of the weight of the liver is obvious.
Compared with the model group, the epididymal fat of the mice of the sample 2, the sample 6 and the sample 7 has no significant difference, and one or two fermentation stock solutions are lacked in the raw materials of the three samples, so that the results show that both the aloe fermentation stock solution and the comprehensive fruit and vegetable fermentation stock solution have influence on the epididymal fat of the mice. Compared with the model group, the epididymal fat of the mice in the sample 1 group has no obvious difference, and the raw materials of the sample 1 group do not contain rare sugar, which shows that the rare sugar plays a main role in reducing the epididymal fat of the mice. Meanwhile, compared with the model group, the sample 2 group containing only rare sugar in the raw materials has lower epididymal fat reduction degree than the sample 3-10 group, which shows that the compounding of the fermentation stock solution and the rare sugar has the synergistic effect. The raw materials of the 8-10 groups of samples respectively contain two kinds of rare sugar and two kinds of fermentation stock solutions, the epididymis fat of mice is reduced remarkably, but the reduction degree is lower than that of the 3-5 groups of samples, and the reduction effect of the compounding of the three kinds of oligosaccharide and the two kinds of fermentation stock solutions on the epididymis fat of the mice is most remarkable. Among them, the fat-reducing effect of epididymis was the best in sample 5.
Compared with the model group, the perirenal fat of the mice of the sample 2 and the sample 6 has no obvious difference, while the perirenal fat of the mice of the sample 7 is obviously reduced, which shows that the aloe fermentation stock solution and the combination of the three kinds of rare sugar have the synergistic effect and can obviously reduce the perirenal fat of the mice. Compared with the model group, the perirenal fat of the mice in the sample 1 group has no significant difference, which shows that only two fermentation stock solutions have insignificant effect on reducing the perirenal fat of the mice. Meanwhile, compared with the model group, the perirenal fat reduction degree of the sample 2 group containing only rare sugar in the raw materials is lower than that of the sample 3-10 group, which shows that the compounding of the fermentation stock solution and the rare sugar has the synergistic effect. The perirenal fat of mice in the 8-10 groups of samples is obviously reduced, the raw materials respectively contain two kinds of rare sugar, but the reduction degree is lower than that of the 3-5 groups of samples, and the reduction effect of the combination of the three kinds of oligosaccharide and the two kinds of rare sugar on the perirenal fat of the mice is most obvious. Among them, the sample 5 group had the best effect of reducing perirenal fat.
TABLE 4 mean weights of mouse tissues
Note: # indicates significance compared to the blank control group and # indicates significance compared to the model control group.
2.3 analysis of the species diversity of the intestinal flora
The abundance and diversity of microbial communities can be reflected by a diversity analysis (α diversity) of a single sample. Judging the abundance of the flora by using a Chao index, wherein the larger the Chao index is, the higher the abundance of the flora is. The diversity of the flora was estimated by Shannon and Simpson indices. The larger the Shannon index, the higher the community diversity. The larger the Simpson index, the lower the community diversity.
The alpha diversity index of the intestinal flora of the mice of each group of samples is shown in table 5, and the results show that the species abundance degree Chao index of the model group is obviously reduced compared with that of a blank control group, the species diversity Shannon index is obviously reduced compared with that of a control group, and the Simpson index is obviously increased compared with that of the control group, which indicates that the species abundance degree and species diversity of the intestinal flora of the obese mice are obviously reduced compared with that of the control group. Compared with the model group, the Chao indexes show a rising trend after the ferment samples 1-10 are administered; except for the sample 1 and 2 groups, the Shannon indexes of the rest groups show a rising trend, wherein the sample 5 group is greatly increased compared with the model group; the Simpson index is reduced, the sample 9 group is obviously reduced compared with the model group, the sample 3 group is obviously reduced compared with the model group, and the samples 4 and 5 group are extremely obviously reduced compared with the model group (p is less than 0.01 in the sample 4 group and p is less than 0.001 in the sample 5 group), which indicates that the ferment increases the abundance of floras and increases the diversity of mouse intestinal floras.
TABLE 5 mouse intestinal flora alpha diversity index
Note: # indicates significance compared to the blank control group and # indicates significance compared to the model control group.
In conclusion, the ferment disclosed by the invention has obvious effects of preventing obesity and regulating intestinal flora, can reduce the weight gain of mice, reduce the weight of liver, perirenal fat and epididymal fat, and can increase the diversity of the intestinal flora of the mice.
Claims (8)
1. The ferment for preventing obesity and regulating intestinal flora is characterized by being prepared by fermenting the following raw materials: 20-40 parts of aloe fermentation stock solution, 40-60 parts of comprehensive fruit and vegetable fermentation stock solution, 1-15 parts of fructo-oligosaccharide, 1-15 parts of galacto-oligosaccharide and 1-10 parts of trehalose.
2. The ferment for preventing obesity and regulating intestinal flora according to claim 1, wherein the ferment is prepared by fermenting the following raw materials: 15-25 parts of aloe fermentation stock solution, 45-55 parts of comprehensive fruit and vegetable fermentation stock solution, 3-12 parts of fructo-oligosaccharide, 3-12 parts of galacto-oligosaccharide and 2-8 parts of trehalose.
3. The ferment for preventing obesity and regulating intestinal flora according to claim 1 or 2, wherein the aloe is at least one of aloe vera, aloe arborescens and aloe vera.
4. The ferment for preventing obesity and regulating intestinal flora according to claim 3, wherein the aloe is aloe gel, and the aloe gel is prepared by using the aloe leaves as a raw material and performing steps of leaching quinone, cleaning, peeling, blanching and sterilizing.
5. The ferment for preventing obesity and regulating intestinal flora according to claim 1 or 2, wherein the fruit and vegetable raw materials of the integrated fruit and vegetable fermentation stock solution comprise: lemon, green plum, papaya, kiwi fruit, mulberry, medlar, red date and/or rose.
6. The ferment for preventing obesity and regulating intestinal flora according to claim 5, wherein the fruit and vegetable raw materials of the integrated fruit and vegetable fermentation stock solution further comprise: pineapple, plum, grape, dragon fruit, apple, hawthorn, green tea, okra, corn, mushroom, prune, noni, dark plum, citrus, grapefruit, and/or blueberry.
7. The method for preparing ferment for preventing obesity and regulating intestinal flora according to any one of claims 1 to 6, wherein the method comprises the following steps:
fermentation in the first stage: fermenting the aloe and the fruit and vegetable raw materials at normal temperature for 3 months to 2 years respectively;
and (3) second-stage fermentation: mixing the aloe and fruit and vegetable fermentation stock solution obtained in the first stage fermentation with the rare sugar according to the weight ratio, and fermenting by adopting lactobacillus plantarum and/or saccharomycetes at the fermentation temperature of 25-36 ℃ for 7-30 days.
8. Use of the ferment for preventing obesity and regulating intestinal flora according to any one of claims 1 to 7 in the preparation of a medicament or food for preventing obesity and regulating intestinal flora function.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210213988.4A CN114468280A (en) | 2022-03-04 | 2022-03-04 | Enzyme for preventing obesity and regulating intestinal flora and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210213988.4A CN114468280A (en) | 2022-03-04 | 2022-03-04 | Enzyme for preventing obesity and regulating intestinal flora and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114468280A true CN114468280A (en) | 2022-05-13 |
Family
ID=81486260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210213988.4A Pending CN114468280A (en) | 2022-03-04 | 2022-03-04 | Enzyme for preventing obesity and regulating intestinal flora and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114468280A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116076717A (en) * | 2023-03-02 | 2023-05-09 | 美益添生物医药(武汉)有限公司 | Composition for regulating intestinal microbial environment and preparation method and application thereof |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103300447A (en) * | 2013-04-22 | 2013-09-18 | 湖北汇丰医药科技有限公司 | Wellness enzyme beverage capable of promoting in-vivo metabolism and coordinating intestine and stomach functions and preparation method thereof |
CN104921141A (en) * | 2015-06-24 | 2015-09-23 | 润盈生物工程(上海)有限公司 | Preparation method of composite probiotic fruit and vegetable enzyme |
CN105285993A (en) * | 2015-11-23 | 2016-02-03 | 广西职业技术学院 | Passion fruit enzyme powder and preparation method thereof |
CN105919097A (en) * | 2016-05-13 | 2016-09-07 | 张良 | Aloe enzyme preparing method and prepared aloe enzyme |
CN107048360A (en) * | 2017-04-11 | 2017-08-18 | 姜红成 | Prepare the fermentation composition and preparation method of the plant enzyme with recuperating gastrointestinal tract function of relaxing bowel |
CN107125745A (en) * | 2017-06-30 | 2017-09-05 | 张萌 | Adjust ferment of gut flora and bowel relaxing functions and preparation method thereof |
CN107535782A (en) * | 2017-08-07 | 2018-01-05 | 云南肠和健康科技股份有限公司 | A kind of aloe barbadensis Miller enzyme beverage and preparation method thereof |
CN107691939A (en) * | 2017-08-11 | 2018-02-16 | 杭州千济方健康管理有限公司 | A kind of enzyme stoste beverage |
CN109123645A (en) * | 2018-09-30 | 2019-01-04 | 山东天随生物科技有限公司 | A kind of fruits and vegetables composite enzyme and its production method |
CN109567168A (en) * | 2018-12-29 | 2019-04-05 | 熊永东 | A kind of enteron aisle toxin expelling enzyme food |
CN110179032A (en) * | 2019-07-16 | 2019-08-30 | 山东天随生物科技有限公司 | A kind of Noni fruit composite enzyme and its production method |
CN111264852A (en) * | 2020-03-06 | 2020-06-12 | 王晓珑 | Composite fruit and vegetable enzyme stock solution with long fermentation time and preparation method thereof |
-
2022
- 2022-03-04 CN CN202210213988.4A patent/CN114468280A/en active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103300447A (en) * | 2013-04-22 | 2013-09-18 | 湖北汇丰医药科技有限公司 | Wellness enzyme beverage capable of promoting in-vivo metabolism and coordinating intestine and stomach functions and preparation method thereof |
CN104921141A (en) * | 2015-06-24 | 2015-09-23 | 润盈生物工程(上海)有限公司 | Preparation method of composite probiotic fruit and vegetable enzyme |
CN105285993A (en) * | 2015-11-23 | 2016-02-03 | 广西职业技术学院 | Passion fruit enzyme powder and preparation method thereof |
CN105919097A (en) * | 2016-05-13 | 2016-09-07 | 张良 | Aloe enzyme preparing method and prepared aloe enzyme |
CN107048360A (en) * | 2017-04-11 | 2017-08-18 | 姜红成 | Prepare the fermentation composition and preparation method of the plant enzyme with recuperating gastrointestinal tract function of relaxing bowel |
CN107125745A (en) * | 2017-06-30 | 2017-09-05 | 张萌 | Adjust ferment of gut flora and bowel relaxing functions and preparation method thereof |
CN107535782A (en) * | 2017-08-07 | 2018-01-05 | 云南肠和健康科技股份有限公司 | A kind of aloe barbadensis Miller enzyme beverage and preparation method thereof |
CN107691939A (en) * | 2017-08-11 | 2018-02-16 | 杭州千济方健康管理有限公司 | A kind of enzyme stoste beverage |
CN109123645A (en) * | 2018-09-30 | 2019-01-04 | 山东天随生物科技有限公司 | A kind of fruits and vegetables composite enzyme and its production method |
CN109567168A (en) * | 2018-12-29 | 2019-04-05 | 熊永东 | A kind of enteron aisle toxin expelling enzyme food |
CN110179032A (en) * | 2019-07-16 | 2019-08-30 | 山东天随生物科技有限公司 | A kind of Noni fruit composite enzyme and its production method |
CN111264852A (en) * | 2020-03-06 | 2020-06-12 | 王晓珑 | Composite fruit and vegetable enzyme stock solution with long fermentation time and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116076717A (en) * | 2023-03-02 | 2023-05-09 | 美益添生物医药(武汉)有限公司 | Composition for regulating intestinal microbial environment and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
CN107279981A (en) | Composite plant zymotic fluid and its zymotechnique and application | |
CN107568537A (en) | A kind of compound microorganism ferments beverage containing anthocyanidin and preparation method thereof | |
CN111066989A (en) | Compound beverage and preparation method thereof | |
US10294495B2 (en) | Fermented mineral raw-edible pill with constipation reduction and fatigue recovery and method for producing the same | |
CN108968058A (en) | It is a kind of improve enteron aisle probiotics enzyme composition and application | |
CN106579387A (en) | Arabinose-enzyme composition and preparation method thereof | |
CN112617182B (en) | Plant enzyme composition for weight management and preparation method thereof | |
CN111227261A (en) | Prebiotic composition and application thereof | |
CN111329055B (en) | Preparation method of trifoliate acanthopanax enzyme | |
CN111642753A (en) | Dietary nutrition supplement composition and preparation method thereof | |
CN114468280A (en) | Enzyme for preventing obesity and regulating intestinal flora and preparation method and application thereof | |
CN114617254A (en) | Grape seed, angelica dahurica and mulberry enzyme with functions of maintaining beauty, keeping young, moistening intestines and relaxing bowels | |
CN117946939A (en) | Lactobacillus plantarum SM2 and application thereof in preparation of cholesterol-lowering and sleep-aiding foods and medicines | |
CN110547447A (en) | Royal jelly collagen fruit enzyme and preparation method thereof | |
CN116211956B (en) | Composition for regulating intestinal tract and/or improving obesity, preparation method, chewable tablet and application thereof | |
CN104026589B (en) | A kind of peptide ferment and preparation method thereof | |
CN115777933A (en) | Composition for regulating metabolism, reducing fat and controlling sugar and application thereof | |
CN115553406A (en) | Weight-reducing composition beverage for inhibiting absorption of fat and sugar substances and preparation method thereof | |
CN109043259A (en) | A kind of ferment L-arabinose stachyose composite beverage underflow | |
CN115211508A (en) | Enzyme beverage and preparation method thereof | |
KR20220052580A (en) | Preparation method of psyllium powder fermented by lactic acid bacteria | |
CN112586733A (en) | Ferment fermentation stock solution with constipation improving function and preparation method and application thereof | |
KR101925124B1 (en) | Manufacturing method for fermented drink using vegetable sourse | |
Stetsenko et al. | Development of a method for producing a healthy drink based on fermented beet juice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220513 |
|
RJ01 | Rejection of invention patent application after publication |